Take this FDA-approved diabetes drug, and you might have to amputate your leg, warns the FDA

(Natural News) The U.S. Food and Drug Administration (FDA) has recently issued a black box warning against Johnson & Johnson’s Type 2 diabetes drug Invokana as the medication was found to increase the risk of amputation in patients. Data from two clinical trials showed that patients taking canagliflozin, the drug’s generic name, had higher incidence of amputations than…

>View original article